Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research

Cancer

Volumn 115, Issue 12, 2009, Pages 2783-2791

  Jagsi, Reshma ^a,b   Sheets, Nathan ^b   Jankovic, Aleksandra ^b   Motomura, Amy R ^a   Amarnath, Sudha ^b   Ubel, Peter A ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Conflict of interest; Neoplasms; Publications; Research

Indexed keywords

ARTICLE; CANCER RESEARCH; CANCER SURVIVAL; CANCER THERAPY; CLINICAL RESEARCH; CONFLICT OF INTEREST; CONTROLLED STUDY; FUNDING; MEDICAL LITERATURE; METHODOLOGY; PRIORITY JOURNAL; PUBLICATION; SELF REPORT;

ACADEMIC MEDICAL CENTERS; ACADEMIES AND INSTITUTES; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; DRUG INDUSTRY; MEDICAL ONCOLOGY; PERIODICALS AS TOPIC; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RESEARCH SUPPORT AS TOPIC; TREATMENT OUTCOME;

EID: 67649204117     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24315     Document Type: Article

References (54)

1. Blumenthal D, Campbell EG, Causino N, Louis KS. Participation of life-science faculty in research relationships with industry. N Engl J Med. 1996;335:1734-1739. (Pubitemid 26399349)
2. Blumenthal D, Gluck M, Louis KS, et al. University-industry research relationships in biotechnology: implications for the university. Science. 1986;232:1361-1366. (Pubitemid 16059386)
3. Krimsky S, Rothenberg LS, Stott P, Kyle G. Scientific journals and their authors' financial interests: a pilot study. Psychother Psychosom. 1998;67:194-201.
4. Boyd EA, Bero LA. Assessing faculty financial relationships with industry. JAMA. 2000;284:2209-2214.
5. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research. JAMA. 2003;289:454-465.
6. Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med. 1986;1:155-158.
7. Yaphe J, Edman R, Knishkowy B, Herman J. The association between funding by commercial interests and study outcome in randomized controlled drug trials. Fam Pract. 2001;18:565-568. (Pubitemid 34026576)
8. Djulbegovic B, Lacevic M, Cantor A, et al. The uncertainty principle and industry-sponsored research. Lancet. 2000;356:635-638. (Pubitemid 30627590)
9. Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med. 1996;124:485-489.
10. Turner C, Spilich GJ. Research into smoking or nicotine and human cognitive performance: does the source of funding make a difference? Addiction. 1997;92:1423-1426.
11. Friedberg M, Saffran B, Stinson TJ, Nelson W, Bennett CL. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA. 1999;282:1453-1457. (Pubitemid 29493799)
12. Swaen G, Meijers J. Influence of design characteristics on the outcome of retrospective cohort studies. Br J Ind Med. 1988;45:624-629. (Pubitemid 18225618)
13. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994;154:157-163. (Pubitemid 24980392)
14. Stelfox HT, Chua G, O'Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998;338:101-106. (Pubitemid 28042274)
15. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998;279:1566-1570. (Pubitemid 28233013)
16. Kjaergard L, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ. 2002;325:249-253. (Pubitemid 34864391)
17. Johansen HK, Gotzsche PC. Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA. 1999;282:1752-1759. (Pubitemid 29533606)
18. Rabino I. Societal and commercial issues affecting the future of biotechnology in the United States: a survey of researchers' perceptions. Naturwissenschaften. 1998;85:109-116. (Pubitemid 28166726)
19. McCrary SV, Anderson CB, Jakovljevic J, et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med. 2000;343:1621-1626. (Pubitemid 32162987)
20. Krimsky S, Rothenberg L. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics. 2001;7:205-218.
21. Hussain A, Smith R. Declaring financial competing interests: survey of 5 general medical journals. BMJ. 2001;323:263-264.
22. Riechelmann RP, Wang L, O'Carroll A, Krzyanowska MK. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol. 2007;25:4642-4647. (Pubitemid 350035325)
23. Rettig RA. The industrialization of clinical research. Health Aff (Millwood). 2000;19:129-146.
24. Jagsi R, Guancial EA, Worobey CC, et al. The "gender gap" in authorship of academic medical literature - A 35-year perspective. N Engl J Med. 2006;355:281-287.
25. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall; 1991.
26. Hampson LA, Joffe S, Fowler R, Verter J, Emanuel EJ. Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. J Clin Oncol. 2007;25:3609-3614. (Pubitemid 47372598)
27. Krzyzanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA. 2003;290:495-501. (Pubitemid 37430503)
28. Djulbegovic B, Angelotta C, Knox KE, Bennett CL. The sound and the fury: financial conflicts of interest in oncology. J Clin Oncol. 2007;25:3567-3569. (Pubitemid 47372591)
29. Tuech JJ, Moutel G, Pessaux P, et al. Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Eur J Cancer. 2005;41:2237-2240. (Pubitemid 41415598)
30. Dieppe P, Chard J, Tallon D, Egger M. Funding clinical research. Lancet. 1999;353:1626. (Pubitemid 29219231)
31. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326:1167-1170. (Pubitemid 36649048)
32. Als-Nielsen B, Chen W, Gluud C, et al. Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? JAMA. 2003;290:921-928.
33. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ. 2004;170:477-480. (Pubitemid 38293642)
34. Friedman LS, Richter ED. Relationship between conflicts of interest and research results. J Gen Intern Med. 2004;19:51-56.
35. Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. JAMA. 2006;295:2270-2274.
36. Kelly RE, Cohen LJ, Semple RJ, et al. Relationship between drug company funding and outcomes of clinical psychiatric research. Psychol Med. 2006;36:1647-1656. (Pubitemid 44575810)
37. Montgomery JH, Byerly M, Carmody T, et al. An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia. Contr Clin Trials. 2004;25:598-612. (Pubitemid 39592864)
38. Brown A, Kraft D, Schmitz SM, et al. Association of industry sponsorship to published outcomes in gastrointestinal research. Clin Gastroenterol Hepatol. 2006;4:1445-1451. (Pubitemid 44880026)
39. Shah RV, Albert TJ, Bruegel-Sanchez V, et al. Industry support and correlation to study outcome for papers published in Spine. Spine. 2005;30:1099-1104. (Pubitemid 40663920)
40. Leopold SS, Warme WJ, Fritz Braunlich E, et al. Association between funding source and study outcome in orthopaedic research. Clin Ortho Relat Res. 2003;415:293-301. (Pubitemid 37329067)
41. Cunningham MR, Warme WJ, Schaad DC, Wolf FM, Leopold SS. Industry-funded positive studies not associated with better design or larger size. Clin Orthop Relat Res. 2007;457:235-241. (Pubitemid 46573421)
42. Clifford TJ, Barrowman NJ, Moher D. Funding source, trial outcome, and reporting quality: are they related? Results of a pilot study. BMC Health Serv Res. 2002;2:18. (Pubitemid 38994248)
43. Knox KS, Adams JR, Djulbegovic B, et al. Reporting and dissemination of industry versus non-profit sponsored economic analyses of 6 novel drugs used in oncology. Ann Oncol. 2000;11:1591-1595. (Pubitemid 32104759)
44. Hartmann M, Knoth H, Schulz D, Knoth S. Industry-sponsored economic studies in oncology vs studies sponsored by nonprofit organizations. Br J Cancer. 2003;89:1405-1408. (Pubitemid 37386591)
45. Peppercorn J, Blood E, Winer E, Partridge A. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Cancer. 2007;109:1239-1246. (Pubitemid 46466549)
46. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252-260.
47. Angell M. Industry-sponsored clinical research: a broken system. JAMA. 2008;300:1069-1071.
48. [No authors listed]. Authorship responsibility, financial disclosure, and copyright transfer (Cancer Web site). Available at http://www3.interscience. wiley.com/homepages/28741/nscta.pdf. Accessed June 4, 2008.
49. [No authors listed]. Information for authors (Clinical Cancer Research Web site). Available at: http://clincancer-res.aacrjournals.org/misc/ifora. shtml. Accessed June 4, 2008.
50. [No authors listed]. Instructions for authors (Journal of the American Medical Association Web site). Available at: http://jama.ama-assn.org/misc/ ifora.dtl. Accessed June 4, 2008.
51. American Society of Clinical Oncology. American Society of Clinical Oncology: revised conflict of interest policy. J Clin Oncol. 2006;24:519-521.
52. [No authors listed]. Instructions to authors. (Journal of the National Cancer Institute Web site). Available at: http://www.oxfordjournals.org/our- journals/jnci/for-authors/index. html#coninterest. Accessed June 4, 2008.
53. James A, Horton R, Collingridge D, McConnell J, Butcher J. The Lancet's policy of conflicts of interest - 2004. Lancet. 2004;363:2-3. (Pubitemid 38076913)
54. [No authors listed]. How to prepare your financial disclosure statement (New England Journal of Medicine website). Available at: http://authors.nejm. org/help/disclos.asp Accessed June 4, 2008.